PubRank

Thomas D Harris

Author PubWeight™ 20.55‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. Cancer Res 2003 2.70
2 Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. Arterioscler Thromb Vasc Biol 2006 2.45
3 Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticles. Magn Reson Med 2005 2.30
4 Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction. J Clin Invest 2004 2.06
5 Detection of injury-induced vascular remodeling by targeting activated alphavbeta3 integrin in vivo. Circulation 2004 1.57
6 Scintigraphic imaging of infectious foci with an 111In-LTB4 antagonist is based on in vivo labeling of granulocytes. J Nucl Med 2005 1.47
7 90Y and 111In complexes of a DOTA-conjugated integrin alpha v beta 3 receptor antagonist: different but biologically equivalent. Bioconjug Chem 2004 1.13
8 MR three-dimensional molecular imaging of intramural biomarkers with targeted nanoparticles. J Cardiovasc Magn Reson 2006 0.87
9 Assessment of myocardial inflammation produced by experimental coronary occlusion and reperfusion with 99mTc-RP517, a new leukotriene B4 receptor antagonist that preferentially labels neutrophils in vivo. Circulation 2002 0.83
10 A bivalent leukotriene B(4) antagonist for scintigraphic imaging of infectious foci. J Nucl Med 2003 0.83
11 Alphavbeta3-targeted detection of arteriopathy in transplanted human coronary arteries: an autoradiographic study. FASEB J 2005 0.82
12 Scintigraphic detection of pulmonary aspergillosis in rabbits with a radiolabeled leukotriene b4 antagonist. J Nucl Med 2004 0.78
13 Synthesis of leukotriene B4 antagonists labeled with In-111 or Tc-99m to image infectious and inflammatory foci. J Med Chem 2005 0.78
14 Imaging of infection and inflammation with an improved 99mTc-labeled LTB4 antagonist. J Nucl Med 2005 0.78
15 Anaerobic 90Y- and 177Lu-labeling of a DOTA-conjugated nonpeptide vitronectin receptor antagonist. Bioconjug Chem 2003 0.76
16 Imaging of experimental colitis with a radiolabeled leukotriene B4 antagonist. J Nucl Med 2004 0.76